Search research articles
Contact Us
Filters
Showing results (111-120 of 201) with videos related to
Page
of 21
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2007
Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study
Peter G Rose, Shamshad Ali, Edwin Watkins, et al.
Anti-Cancer Drugs
|
July 23, 2020
Incidence of squamous cell carcinomas of the head and neck following prolonged pegylated liposomal doxorubicin
Peter G Rose, Frances Fu, Laura M Chambers, et al.
Gynecologic Oncology
|
July 27, 2015
Outcome of neoadjuvant chemotherapy in BRCA1/2 mutation positive women with advanced-stage Müllerian cancer
Haider Mahdi, Allison Gockley, Katherine Esselen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2015
Nomograms Predicting Progression-Free Survival, Overall Survival, and Pelvic Recurrence in Locally Advanced Cervical Cancer Developed From an Analysis of Identifiable Prognostic Factors in Patients From NRG Oncology/Gynecologic Oncology Group Randomized Trials of Chemoradiotherapy
Peter G Rose, James Java, Charles W Whitney, et al.
Gynecologic Oncology
|
August 6, 2014
A Phase II evaluation of ixabepilone (IND #59699, NSC #710428) in the treatment of recurrent or persistent leiomyosarcoma of the uterus: an NRG Oncology/Gynecologic Oncology Group Study
Linda R Duska, John A Blessing, Jacob Rotmensch, et al.
Journal of Gynecology Obstetrics and Human Reproduction
|
June 27, 2020
Effect of platinum sensitivity on the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) in recurrent epithelial ovarian cancer
Anthony B Costales, Laura Chambers, Anna Chichura, et al.
Gynecologic Oncology
|
May 1, 2024
Extended-duration antibiotics are not associated with a reduction in surgical site infection in patients with ovarian cancer undergoing cytoreductive surgery with large bowel resection
Julia Chalif, Laura M Chambers, Meng Yao, et al.
Gynecologic Oncology
|
March 11, 2022
Incidence and prognostic significance of inguinal lymph node metastasis in women with newly diagnosed epithelial ovarian cancer
Julia Chalif, Meng Yao, Morgan Gruner, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 11, 2026
Interval versus primary cytoreductive surgery in BRCA-mutated advanced-stage ovarian/peritoneal/tubal carcinoma
Peter G Rose, Sujata Patil, Meng Yao, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 6, 2023
Efficacy and toxicity of carboplatin and gemcitabine administered on day 1 and day 8 (day1&8) versus day 1-only for platinum-sensitive recurrent epithelial ovarian cancer
Erika J Lampert, Peter G Rose, Meng Yao, et al.
Page
of 21
Search research articles
Search
Showing results (111-120 of 201) with videos related to
Sort By:
Page
of 21
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2007
Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study
Peter G Rose, Shamshad Ali, Edwin Watkins, et al.
Anti-Cancer Drugs
|
July 23, 2020
Incidence of squamous cell carcinomas of the head and neck following prolonged pegylated liposomal doxorubicin
Peter G Rose, Frances Fu, Laura M Chambers, et al.
Gynecologic Oncology
|
July 27, 2015
Outcome of neoadjuvant chemotherapy in BRCA1/2 mutation positive women with advanced-stage Müllerian cancer
Haider Mahdi, Allison Gockley, Katherine Esselen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2015
Nomograms Predicting Progression-Free Survival, Overall Survival, and Pelvic Recurrence in Locally Advanced Cervical Cancer Developed From an Analysis of Identifiable Prognostic Factors in Patients From NRG Oncology/Gynecologic Oncology Group Randomized Trials of Chemoradiotherapy
Peter G Rose, James Java, Charles W Whitney, et al.
Gynecologic Oncology
|
August 6, 2014
A Phase II evaluation of ixabepilone (IND #59699, NSC #710428) in the treatment of recurrent or persistent leiomyosarcoma of the uterus: an NRG Oncology/Gynecologic Oncology Group Study
Linda R Duska, John A Blessing, Jacob Rotmensch, et al.
Journal of Gynecology Obstetrics and Human Reproduction
|
June 27, 2020
Effect of platinum sensitivity on the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) in recurrent epithelial ovarian cancer
Anthony B Costales, Laura Chambers, Anna Chichura, et al.
Gynecologic Oncology
|
May 1, 2024
Extended-duration antibiotics are not associated with a reduction in surgical site infection in patients with ovarian cancer undergoing cytoreductive surgery with large bowel resection
Julia Chalif, Laura M Chambers, Meng Yao, et al.
Gynecologic Oncology
|
March 11, 2022
Incidence and prognostic significance of inguinal lymph node metastasis in women with newly diagnosed epithelial ovarian cancer
Julia Chalif, Meng Yao, Morgan Gruner, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 11, 2026
Interval versus primary cytoreductive surgery in BRCA-mutated advanced-stage ovarian/peritoneal/tubal carcinoma
Peter G Rose, Sujata Patil, Meng Yao, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 6, 2023
Efficacy and toxicity of carboplatin and gemcitabine administered on day 1 and day 8 (day1&8) versus day 1-only for platinum-sensitive recurrent epithelial ovarian cancer
Erika J Lampert, Peter G Rose, Meng Yao, et al.
Page
of 21